Cormorant Asset Management, Lp Apellis Pharmaceuticals, Inc. (APLS) insider trading activity
Cormorant Asset Management, LP is > 10% Shareholder of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 3.47 Million shares of APLS, which is worth approximately $100 Million. The most recent transaction as insider was on Nov 13, 2017, when has been sold 1,071,428 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $14,999,992. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.47M
0%
3M change
0%
12M change
Total Value Held
$100 Million
Cormorant Asset Management, LP Transaction History
Also insider at
CAM
Cormorant Asset Management, LP
> 10% Shareholder
Boston, MA